Clinical Trial Update: Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia [Phase 3]

View source ↗

Summary

A Phase 3 trial reports safety and efficacy results for zirconium silicate in treating mild to moderate hyperkalemia. Completion and results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• zirconium silicate (zirconium silicate)

Snippet

Sponsor: ZS Pharma, Inc. | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-12